HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
61 hedge funds and large institutions have $436M invested in HilleVax in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
11% more funds holding
Funds holding: 55 → 61 (+6)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less capital invested
Capital invested by funds: $440M → $436M (-$3.96M)
11.61% less ownership
Funds ownership: 78.9% → 67.28% (-12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carlyle Group
Washington,
District of Columbia
|
+$29.4M |
| 2 |
DM
Deerfield Management
New York
|
+$2.23M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.3M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$614K |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$370K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.36M |
| 2 |
FAM
Fred Alger Management
New York
|
-$331K |
| 3 |
Invesco
Atlanta,
Georgia
|
-$284K |
| 4 |
Morgan Stanley
New York
|
-$157K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$154K |
HLVX Hedge Fund Activity: Q1 2023 in Review
61 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2023, worth a combined $436M — down 0.9% from $440M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new HLVX positions and 4 closed out — a net gain of 7 holders — while 20 added to existing stakes and 17 trimmed.
The largest buyer was Carlyle Group, opening a new position worth an estimated $29.4M. The largest seller was Vanguard Group, cutting an estimated $3.36M.
- 61 institutional investors held HilleVax (HLVX) as of Q1 2023, up from 55 in Q4 2022.
- Funds reported $436M of HilleVax stock for Q1 2023, down 0.9% quarter-over-quarter.
- 11 funds opened new HilleVax positions in Q1 2023 and 4 closed out, a net change of +7 holders.
- The largest HilleVax buyer in Q1 2023 was Carlyle Group, an estimated $29.4M added.
- The largest HilleVax seller in Q1 2023 was Vanguard Group, an estimated $3.36M sold.
Based on aggregated 13F filings for Q1 2023.